HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

NCT00412022 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1294

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: tamoxifen
DRUG: triptorelin
DRUG: letrozole
DRUG: zoledronic acid

Sponsor

National Cancer Institute, Naples

Collaborators

[object Object]